{"id":"F2018L00510","name":"Therapeutic Goods (Biologicals—Conditions of Inclusion in Register) Determination 2018","slug":"therapeutic-goods-biologicals-conditions-of-inclusion-in-register-determination-2018","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"in_force","isInForce":true,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":100015,"registerId":"commonwealth-F2018L00510-current","compilationNumber":null,"startDate":"2026-04-02","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Name","content":"#### 1 Name\n\n  This instrument is the Therapeutic Goods (Biologicals—Conditions of Inclusion in Register) Determination 2018.","sortOrder":0},{"sectionNumber":"2","sectionType":"section","heading":"Commencement","content":"#### 2 Commencement\n\n  This instrument commences on the day after it is registered.","sortOrder":1},{"sectionNumber":"3","sectionType":"section","heading":"Definitions","content":"#### 3 Definitions\n\n  In this instrument:\n\n> Act means the Therapeutic Goods Act 1989.","sortOrder":2},{"sectionNumber":"4","sectionType":"section","heading":"Conditions of inclusion in Register—reporting and record-keeping","content":"#### 4 Conditions of inclusion in Register—reporting and record-keeping\n\n  For the purposes of paragraphs 32EC(2)(c) and (ca) of the Act, a person in relation to whom a biological is included in the Register must:\n    (a) in relation to each distribution of the biologicals—keep a record of the distribution at least until the end of the period of 10 years after the distribution; and\n    (b) comply with the record-keeping requirements and the reporting requirements set out in the document titled Biovigilance Responsibilities of Sponsors of Biologicals – Australian requirements and recommendations, version 1.0, published by the Therapeutic Goods Administration in December 2017.\n\n> Note: A copy of the document mentioned in paragraph 4(b) is available on the Therapeutic Goods Administration website (www.tga.gov.au).","sortOrder":3},{"sectionNumber":"5","sectionType":"section","heading":"Conditions of inclusion in Register—variations","content":"#### 5 Conditions of inclusion in Register—variations\n\n  For the purposes of paragraph 32EC(2)(e), a person in relation to whom a biological is included in the Register must not implement a variation to, or in relation to, the biological before the Secretary approves the variation by varying the entry in the Register that relates to the biological under section 9D of the Act.","sortOrder":4}],"analysis":{"flash_summary_failed":{"failed":true,"reason":"Unauthenticated. Configure AI_GATEWAY_API_KEY or use a provider module. Learn more: https://ai-sdk.dev/unauthenticated-ai-gateway","source":"analysis-cron"},"kimi_summary":{"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"This legislation appears to serve its original narrow purpose: setting specific conditions of inclusion for biologicals on the Register. It has not expanded beyond this scope."},"complexity_factors":["Only 1 defined term ('Act') in the interpretation section","No nested exceptions or conditional logic","Minimal cross-referencing (only references to specific paragraphs of the parent Act)","Short length (5 sections total)","Straightforward obligations: record-keeping, compliance with external document, and pre-approval for variations","External document incorporated by reference but clearly identified with version number and publication date"],"plain_english_summary":"This law requires sponsors of biological medicines listed on Australia’s register to maintain long-term traceability, follow TGA biovigilance guidance, and secure official approval before altering listed products. \n\nIt applies to companies or individuals who bring biologicals (e.g., cell, tissue, blood products, vaccines) to market and matters because these products carry unique safety risks — long records and active safety monitoring let authorities trace issues and protect public health."},"flash_summary":{"complexity_score":3,"scope_assessment":{"changed":false,"description":"The instrument specifies conditions attached to biologicals included in the Register (record‑keeping, reporting and prior approval for variations). It does not, on its face, expand or narrow which biologicals are captured under the Act; it imposes procedural and compliance requirements on persons in relation to Register entries."},"complexity_factors":["Cross-references to the Therapeutic Goods Act (paragraphs 32EC(2)(c),(ca),(e) and section 9D) create reliance on external statutory context.","Dependence on an external guidance document (Biovigilance Responsibilities of Sponsors of Biologicals, Dec 2017) for detailed record‑keeping and reporting requirements.","Administrative discretion: Secretary approval is required before implementing variations (s5), introducing case‑by‑case decisionmaking.","Fixed, long record‑retention period (10 years) imposes a tangible compliance and data‑management burden (s4(a)).","The instrument sets obligations but does not itself detail enforcement mechanisms or procedural timelines for approvals, requiring reference to other instruments or agency practice."],"plain_english_summary":"This Determination attaches conditions to biologicals on the Register: sponsors must keep distribution records for at least 10 years and follow the TGA’s \"Biovigilance Responsibilities of Sponsors of Biologicals\" (Dec 2017) (s4). They also may not implement any variation to a biological before the Secretary approves a Register variation under section 9D of the Act (s5); sponsors therefore incur reporting and approval burdens and the Secretary holds approval discretion."}},"importantCases":[],"_links":{"self":"/api/acts/therapeutic-goods-biologicals-conditions-of-inclusion-in-register-determination-2018","history":"/api/acts/therapeutic-goods-biologicals-conditions-of-inclusion-in-register-determination-2018/history","analysis":"/api/acts/therapeutic-goods-biologicals-conditions-of-inclusion-in-register-determination-2018/analysis","conflicts":"/api/acts/therapeutic-goods-biologicals-conditions-of-inclusion-in-register-determination-2018/conflicts","importantCases":"/api/acts/therapeutic-goods-biologicals-conditions-of-inclusion-in-register-determination-2018/important-cases","documents":"/api/acts/therapeutic-goods-biologicals-conditions-of-inclusion-in-register-determination-2018/documents"}}